AU Patent

AU1525700A — Increasing bone strength with selected bisphosphonates

Assigned to Gador SA · Expires 2000-06-05 · 26y expired

What this patent protects

Patent listed against risedronate-sodium.

Drugs covered by this patent

risedronate-sodium (RISEDRONATE SODIUM)

Patent Metadata

Patent number: AU1525700A
Jurisdiction: AU
Classification: —
Expires: 2000-06-05
Drug substance claim: No
Drug product claim: No
Assignee: Gador SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.